Covered recipient · General Payments record
SAMANTHA BROOKE POZNER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$650.87
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $302.72 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $71.94 | 4 |
| PFIZER INC. | $69.42 | 4 |
| Novo Nordisk AS | $57.08 | 3 |
| ABBVIE INC. | $28.31 | 2 |
| Vertical Pharmaceuticals, LLC | $27.61 | 1 |
| GlaxoSmithKline, LLC. | $16.99 | 1 |
| Abbott Laboratories | $16.16 | 1 |
| Merck Sharp & Dohme Corporation | $15.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.16 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124907250 | CMS |
| ABBVIE INC. | $15.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105305393 | CMS |
| ABBVIE INC. | $13.31 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105305397 | CMS |
| GlaxoSmithKline, LLC. | $16.99 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116010281 | CMS |
| Lilly USA, LLC | $17.46 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135388525 | CMS |
| Lilly USA, LLC | $14.86 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410587 | CMS |
| Lilly USA, LLC | $20.76 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135388527 | CMS |
| Lilly USA, LLC | $18.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135341853 | CMS |
| Merck Sharp & Dohme LLC | $15.21 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141831094 | CMS |
| Novo Nordisk Inc | $20.12 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097583729 | CMS |
| Novo Nordisk Inc | $21.12 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097353307 | CMS |
| Novo Nordisk Inc | $15.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097537595 | CMS |
| PFIZER INC. | $17.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131343114 | CMS |
| PFIZER INC. | $16.40 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132035672 | CMS |
| PFIZER INC. | $18.18 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131856610 | CMS |
| PFIZER INC. | $17.57 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132102913 | CMS |
| Vertical Pharmaceuticals, LLC | $27.61 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126994332 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.